AI Engines For more Details: Perplexity Kagi Labs You
Saturated Fat and Cholesterol: Many animal protein sources, especially red and processed meats, can be high in saturated fat and dietary cholesterol. Diets high in saturated fat and cholesterol have been linked to an increased risk of heart disease, stroke, and other cardiovascular conditions. Consuming large amounts of animal protein, particularly from high-fat cuts and processed meats, may contribute to elevated blood cholesterol levels and worsen cardiovascular health.
Increased Cancer Risk: Some studies have suggested that high consumption of red and processed meats may be associated with an increased risk of certain cancers, particularly colorectal cancer. The mechanisms behind this association are not fully understood but may involve factors such as the presence of heme iron, heterocyclic amines, and polycyclic aromatic hydrocarbons formed during meat cooking processes.
Environmental Impact: Animal agriculture, particularly intensive livestock production, can have significant environmental impacts, including greenhouse gas emissions, water pollution, land degradation, and biodiversity loss. Consuming large amounts of animal protein contributes to these environmental issues and the unsustainable use of natural resources such as water and land. Choosing sustainably sourced and ethically raised animal products or reducing animal protein consumption in favor of plant-based alternatives can help mitigate these environmental effects.
Kidney Function: High intake of animal protein, especially from sources like red meat and processed meats, may put strain on the kidneys and increase the risk of kidney stones or impaired kidney function, particularly in individuals with pre-existing kidney conditions. Moderating intake of animal protein and ensuring adequate hydration can help support kidney health.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.8 | -0.8 | |
| Acne | 1 | -1 | |
| ADHD | 0.9 | 2.4 | -1.67 |
| Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.5 | 0.4 |
| Allergic Rhinitis (Hay Fever) | 0.5 | 0.5 | |
| Allergies | 1.7 | 1 | 0.7 |
| Allergy to milk products | 1.4 | 1.4 | |
| Alopecia (Hair Loss) | 1 | 1 | |
| Alzheimer's disease | 2 | 4.9 | -1.45 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.6 | 0.7 | 2.71 |
| Ankylosing spondylitis | 1.3 | 1.1 | 0.18 |
| Anorexia Nervosa | 0.5 | 3.4 | -5.8 |
| Antiphospholipid syndrome (APS) | 1.1 | 1.1 | |
| Asthma | 1 | 2.5 | -1.5 |
| Atherosclerosis | 0.7 | 1.5 | -1.14 |
| Atrial fibrillation | 2.1 | 1.2 | 0.75 |
| Autism | 3.7 | 5.4 | -0.46 |
| benign prostatic hyperplasia | 0.2 | -0.2 | |
| Bipolar Disorder | 1.9 | 2.7 | -0.42 |
| Brain Trauma | 1.7 | -1.7 | |
| Breast Cancer | 0.2 | 0.4 | -1 |
| Carcinoma | 0.9 | 1.7 | -0.89 |
| Celiac Disease | 1.4 | 3.2 | -1.29 |
| Cerebral Palsy | 1.5 | -1.5 | |
| Chronic Fatigue Syndrome | 0.7 | 2.5 | -2.57 |
| Chronic Kidney Disease | 0.2 | 2.2 | -10 |
| Chronic Lyme | 0.5 | -0.5 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 1 | -0.11 |
| Chronic Urticaria (Hives) | 1.2 | -1.2 | |
| Coagulation / Micro clot triggering bacteria | 1.9 | -1.9 | |
| Colorectal Cancer | 1.2 | 0.7 | 0.71 |
| Constipation | 0.7 | 1.2 | -0.71 |
| Coronary artery disease | 1.1 | 1.5 | -0.36 |
| COVID-19 | 1.9 | 5.1 | -1.68 |
| Crohn's Disease | 4.5 | 5.8 | -0.29 |
| cystic fibrosis | 1 | -1 | |
| deep vein thrombosis | 1.6 | -1.6 | |
| Depression | 3.9 | 5.4 | -0.38 |
| Dermatomyositis | 0.3 | 0.3 | |
| Eczema | 1 | 1 | |
| Endometriosis | 1.7 | 0.4 | 3.25 |
| Epilepsy | 2 | 2 | 0 |
| erectile dysfunction | 0.7 | 0.7 | |
| Fibromyalgia | 1.7 | 1.5 | 0.13 |
| Functional constipation / chronic idiopathic constipation | 2.9 | 1.3 | 1.23 |
| gallstone disease (gsd) | 1.1 | 1 | 0.1 |
| Generalized anxiety disorder | 0.3 | 0.2 | 0.5 |
| giant cell arteritis | 0.2 | 0.2 | |
| Glioblastoma | 1.2 | -1.2 | |
| Gout | 1.2 | -1.2 | |
| Graves' disease | 0.2 | 1.5 | -6.5 |
| Halitosis | 0.3 | -0.3 | |
| Hashimoto's thyroiditis | 2.5 | 0.7 | 2.57 |
| Hemorrhoidal disease, Hemorrhoids, Piles | 0.2 | 0.2 | |
| Hidradenitis Suppurativa | 0.8 | -0.8 | |
| Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.8 | 0.7 | 0.14 |
| hypercholesterolemia (High Cholesterol) | 0.5 | -0.5 | |
| hyperglycemia | 1 | 0.7 | 0.43 |
| hypersomnia | 0.8 | 0.4 | 1 |
| hypertension (High Blood Pressure | 1.3 | 3.5 | -1.69 |
| Hypothyroidism | 0.2 | 2 | -9 |
| IgA nephropathy (IgAN) | 1 | 0.2 | 4 |
| Inflammatory Bowel Disease | 0.9 | 3.4 | -2.78 |
| Insomnia | 0.3 | 1.2 | -3 |
| Intelligence | 1 | 0.7 | 0.43 |
| Intracranial aneurysms | 1 | 0.5 | 1 |
| Irritable Bowel Syndrome | 1.9 | 4 | -1.11 |
| Liver Cirrhosis | 3.2 | 2.5 | 0.28 |
| Long COVID | 5.5 | 4.8 | 0.15 |
| Low bone mineral density | 0.3 | 1.5 | -4 |
| Lung Cancer | 0.2 | 1.5 | -6.5 |
| ME/CFS with IBS | 1.5 | -1.5 | |
| ME/CFS without IBS | 0.3 | 0.2 | 0.5 |
| Metabolic Syndrome | 4.4 | 6 | -0.36 |
| Mood Disorders | 5.7 | 6.2 | -0.09 |
| multiple chemical sensitivity [MCS] | 0.7 | -0.7 | |
| Multiple Sclerosis | 0.9 | 4.5 | -4 |
| Multiple system atrophy (MSA) | 0.5 | 0.4 | 0.25 |
| myasthenia gravis | 0.2 | 0.2 | |
| Neuropathy (all types) | 0.7 | 0.7 | |
| neuropsychiatric disorders (PANDAS, PANS) | 1.5 | -1.5 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.8 | 2.9 | -2.62 |
| Obesity | 4.2 | 5.6 | -0.33 |
| obsessive-compulsive disorder | 1 | 2.7 | -1.7 |
| Osteoarthritis | 0.5 | 1.4 | -1.8 |
| Osteoporosis | 0.7 | 1.8 | -1.57 |
| Parkinson's Disease | 1.4 | 5.3 | -2.79 |
| Polycystic ovary syndrome | 1.4 | 1 | 0.4 |
| Postural orthostatic tachycardia syndrome | 0.2 | 0.2 | 0 |
| Premenstrual dysphoric disorder | 0.3 | 0.2 | 0.5 |
| primary biliary cholangitis | 0.7 | 0.7 | |
| Psoriasis | 0.9 | 0.8 | 0.13 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.3 | 4.2 | -0.27 |
| Rosacea | 0.2 | 0.5 | -1.5 |
| Schizophrenia | 2.3 | 2.5 | -0.09 |
| scoliosis | 1.3 | 0.2 | 5.5 |
| sensorineural hearing loss | 0.5 | -0.5 | |
| Sjögren syndrome | 1.3 | 2.7 | -1.08 |
| Sleep Apnea | 0.7 | 1.5 | -1.14 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.2 | -0.2 | |
| Stress / posttraumatic stress disorder | 0.8 | 2.9 | -2.62 |
| Systemic Lupus Erythematosus | 0.9 | 3.5 | -2.89 |
| Tic Disorder | 0.7 | 0.7 | 0 |
| Type 1 Diabetes | 1.7 | 2.8 | -0.65 |
| Type 2 Diabetes | 3.2 | 4 | -0.25 |
| Ulcerative colitis | 2.6 | 3 | -0.15 |
| Unhealthy Ageing | 0.2 | 2.3 | -10.5 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.